Clinical trial
A Phase 1 Study of AWT020 in Patients With Advanced Solid Tumors
NCT07822919 is registered in ClinicalTrials.gov with Anwita Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of AWT020 in Patients With Advanced Solid Tumors
- Lead sponsor
- Anwita Biosciences
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- September 11, 2026
- Completion date
- February 28, 2029
- Enrollment
- 96 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancers (solid tumors)